(2S,4R,5S)-2-(3-{[5-(4-fluorophenyl)thiophen-2-yl]methyl}-4-methylphenyl)-6-(hydroxymethyl)oxane-3,4,5-triol

• ChemBase编号: 163573
• 分子式: C24H25FO5S
• 平均质量: 444.5157032
• 单一同位素质量: 444.14067312
• SMILES: [C@@H]1([C@@H](C([C@@H](OC1CO)c1cc(c(cc1)C)Cc1ccc(s1)c1ccc(cc1)F)O)O)O
• Canonical SMILES: OCC1O[C@@H](c2ccc(c(c2)Cc2ccc(s2)c2ccc(cc2)F)C)C([C@H]([C@@H]1O)O)O
• InChI: InChI=1S/C24H25FO5S/c1-13-2-3-15(24-23(29)22(28)21(27)19(12-26)30-24)10-16(13)11-18-8-9-20(31-18)14-4-6-17(25)7-5-14/h2-10,19,21-24,26-29H,11-12H2,1H3/t19?,21-,22+,23?,24+/m1/s1
• InChIKey: XTNGUQKDFGDXSJ-PMMPTJNNSA-N

名称和登记号

名称

• IUPAC标准名: (2S,4R,5S)-2-(3-{[5-(4-fluorophenyl)thiophen-2-yl]methyl}-4-methylphenyl)-6-(hydroxymethyl)oxane-3,4,5-triol
• IUPAC传统名: (2S,4R,5S)-2-(3-{[5-(4-fluorophenyl)thiophen-2-yl]methyl}-4-methylphenyl)-6-(hydroxymethyl)oxane-3,4,5-triol
• 别名: (1S)-1,5-Anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methylphenyl]-D-glucitol; Canagliflozin

登记号

• CAS号: 842133-18-0
• PubChem SID: 162257708
• PubChem CID: 71314487

理论计算性质

• Acid pKa: 12.573369
• 质子受体: 5
• 质子供体: 4
• LogD (pH = 5.5): 3.5206552
• LogD (pH = 7.4): 3.520652
• Log P: 3.5206552
• 摩尔折射率: 116.1353 cm^3
• 极化性: 46.202724 Å^3
• 极化表面积: 90.15 Å^2
• 可自由旋转的化学键: 5
• 里宾斯基五规则: true

详细说明

Toronto Research Chemicals - C175190

Canagliflozin is a sodium/glucose cotransporter 2 (SGLT2) inhibitor. Canagliflozin has been shown to dose dependently reduce calculated renal threshold for glucose excretion and increase urinary glucose excretion. Canagliflozin is a candidate for the trea

参考文献

• Chao, E. et al.: Drug Fut., 36, 351 (2011)
• Sha, S. et al.: Diab. Obes. Metab., 13, 669 (2011)
• Kipnes, M.S.: Clin. Invest., 1, 145 (2011)